Data from the present research show that there is a statistically significant decrease in the serum DPPIV activity in patients with melanoma in comparison to healthy controls (p < 0.0004), as well as in comparison to people with vitiligo (p < 0.0004). The gene discussed is DPP4; the disease is vitiligo.